Browse All

Current Filters

CLEAR FILTER x

TITLE

Effects of Bright Light Therapy on Daytime Sleepiness and Depression in Parkinson’s Disease: A Meta-analysis of Randomized Controlled Trials

Author:Messak, Mark   Abdelmageed, Ahmed   Khattab, Youssef A.   Mandour, Youssef   Shaker, Omar   Mohamed, Khaled M.H   Negida, Ahmed   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.003  

Author Institution:Faculty of Medicine, Helwan University, Helwan, Egypt  Faculty of Medicine, Mansoura University, El Mansoura, Egypt  College of Health and Human Sciences, North Dakota State University, Fargo, ND  Virginia Commonwealth University, Richmond, VA  

Efficacy of Cannabinoids on Parkinson’s Disease: An Updated Meta-analysis of Randomized Controlled Trials

Author:Messak, Mark   Abdelmageed, Ahmed   Abbas, Ahmed Noureldeen   Mandour, Youssef   Talkhan, Ahmed   Eltohami, Mahmoud Fadel   Kanaan, Dua’a   Alfahmi, Fawaz K.   Saeed, Habiba Tariq   Hamzeh, Lara Hamzeh   taman, Lamees   Mohamed, Khaled M.H   Negida, Ahmed   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.004  

Author Institution:Faculty of Medicine, Helwan University, Helwan, Egypt  Faculty of Medicine, Mansoura University, El Mansoura, Egypt  Faculty of Medicine, Minia University, Minia, Egypt  Medical Institute of Tambov State University Named After G.R. Derzhavin, Tambov, Russian Federation  School of Medicine, The University of Jordan, Amman, Jordan  College of Medicine, Taif University, Taif, Saudi Arabia  Faculty of Medicine, Tanta University, Tanta, Egypt  Caucasus International University, Tbilisi, Georgia  College of Health and Human Sciences, North Dakota State University, Fargo, ND  Virginia Commonwealth University, Richmond, VA  

Impact on Tremor in Phase Three Trials of Tavapadon: A Selective D1/D5 Agonist for Treatment of Parkinson’s Disease

Author:Torres-Russotto, Diego   Harmer, Linda   Nicholson, Tracy   Bhatia, Perminder   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.005  

Author Institution:Baptist Health South Florida Miami Neuroscience Institute, Miami, FL  AbbVie, Inc., North Chicago, IL  Neuro Pain Medical Center, FRESNO, CA  

Characteristics of OFF-time Improvement in a Phase Two Study for Parkinson’s Disease (PD) with Solengepras, a Novel GPR6-inhibitor

Author:Hauser, Robert   Isaacson, Stuart   Chou, Kelvin   Sarva, Harini   Pahwa, Rajesh   Merchant, Shabbir Hussain   Brice, Nicola   Charles, Michelle   Vaidya, Sagar   Xu, Xiao   McGarry, Andrew   Leinonen, Mika   Kieburtz, Karl   Ellenbogen, Aaron   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.006  

Author Institution:Parkinson’s Disease and Movement Disorders Center, Department of Neurology, University of South Florida, Tampa, FL  Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  University of Michigan Health, Department of Neurology, Ann Arbor, MI  Weill Cornell Medical Center, New York, NY  University of Kansas Medical Center, Kansas City, KS  Beth Israel Deaconess Medical Center, Boston, MA  Cerevance, Cambridge, United Kingdom  Clintrex, FL  Quest Research Institute, Farmington Hills, MI  

exPDite-2: A Phase Three, Randomized, Sham-controlled, Double-blind Trial to Evaluate Bemdaneprocel, a Midbrain Dopaminergic Neuron Progenitor Cell Therapy for Parkinson’s Disease

Author:Abid, Nauman   Adera, Mathews   Louie-Gao, Melinda   Belfort, Gabriel   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.008  

Author Institution:BlueRock Therapeutics, Cambridge, MA